New drug approvals reached an all-time high in 2023, with five gene therapies, the first CRISPR–Cas9-edited therapy and a disease-modifying Alzheimer’s drug.
CITATION STYLE
Senior, M. (2024, March 1). Fresh from the biotech pipeline: record-breaking FDA approvals. Nature Biotechnology. Nature Research. https://doi.org/10.1038/s41587-024-02166-7
Mendeley helps you to discover research relevant for your work.